Glancy Binkow & Goldberg LLP, Representing Shareholders of Zynex, Inc., Announces There are 11 Days Remaining to Move for Appointment as Lead Plaintiff -- ZYXI


LOS ANGELES, May 28, 2009 (GLOBE NEWSWIRE) -- Glancy Binkow & Goldberg LLP announces that all persons or entities who purchased or otherwise acquired the securities of Zynex, Inc. (OTCBB:ZYXI) (formerly Zynex Medical Holdings, Inc.) between May 21, 2008 and March 31, 2009 (the "Class Period") have only 11 days until the June 8, 2009, deadline to move the Court to serve as Lead Plaintiff in the securities fraud class action lawsuit. The case filed by Glancy Binkow & Goldberg LLP, Manandik v. Zynex, Inc., et al., No. 09-cv-00829-REB-KMT, has been assigned to the Honorable Robert E. Blackburn, United States District Judge for the District of Colorado.

A copy of the Complaint is available from the court or from Glancy Binkow & Goldberg LLP. Please contact us by phone to discuss this action or to obtain a copy of the Complaint at (310) 201-9150 or Toll Free at (888) 773-9224, by email at info@glancylaw.com, or visit our website at http://www.glancylaw.com.

The Complaint charges Zynex and certain of the Company's executive officers with violations of sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and S.E.C. Rule 10b-5, and further alleges that throughout the Class Period defendants knew or recklessly disregarded that their public statements concerning the Company's financial performance were materially false and misleading.

The Private Securities Litigation Reform Act of 1995 ("PSLRA") requires the Court to appoint a "Lead Plaintiff" in this case. Any person or group who purchased Zynex securities during the Class Period and suffered a loss may ask the Court to be appointed as Lead Plaintiff, but must file a motion no later than the June 8, 2009 deadline.

Glancy Binkow & Goldberg LLP is a law firm with significant experience in prosecuting class actions, substantial expertise in actions involving corporate fraud, and is representing shareholders of Zynex in this litigation.

If you wish to discuss this action or have any questions concerning this Notice or your rights or interests with respect to these matters, please contact Michael Goldberg, Esquire, or Richard A. Maniskas, Esquire, of Glancy Binkow & Goldberg LLP, 1801 Avenue of the Stars, Suite 311, Los Angeles, California 90067, by telephone at (310) 201-9150 or Toll Free at (888) 773-9224 or by e-mail to info@glancylaw.com.



            

Contact Data